180 Million Indonesians Targets for the COVID-19 Vaccine, Epidemiologists Highlight Immune Response

Liputan6.com, Jakarta – President Joko Widodo said that 170 million to 180 million Indonesians would receive the COVID-19 vaccine. The COVID-19 vaccine, which is currently in phase three clinical trials, is planned to be available in late 2020 or early 2021.

“Insha Alla, at the end of the year or early next year, the vaccine can be injected. This means that the situation can return to normal, but approximately 170 to 180 million people were injected. It took several months, it also requires hard work for all of us,” said Jokowi. when providing Working Capital Assistance to small traders at the Merdeka Palace, Jakarta, Wednesday (30/9/2020).

Epidemiologist Masdalina Pane responded to the 180 million Indonesians who were targeted the COVID-19 vaccine. He highlighted the results of the immune response from the COVID-19 vaccine.

“For us, epidemiologists, the results of the COVID-19 vaccine research itself. Because our sample is small, 1,620 people (the Sinovac vaccine clinical trial in Bandung, West Java). can be seen, “explained Masdalina to Health Liputan6.com by telephone, Friday (2/10/2020).

“1,620 clinical trial participants the COVID-19 vaccine If I’m not mistaken, half of it is also (given) a placebo. A placebo is a vaccine-like substance but not a vaccine. Later the results will be compared with those given the vaccine. “

** Ingat #PesanIbu

Wear a mask, wash your hands with soap, keep your distance and avoid crowds.

Always take care of your health, don’t get infected and take care of our family.

– .